Martin N. Bonde
Chief Executive Officer chez Inthera Bioscience AG
Profil
Martin N.
Bonde was the founder of Aros Pharma ApS (2009) and Azanta Danmark A (2000), where he served as Chief Executive Officer.
Currently, he is the Chief Executive Officer at Inthera Bioscience AG and Chief Executive Officer at Bohrs Tower ApS.
He also holds director positions at Visiopharm A, Biotopix ApS, Bioinnovation Institute, Bii Holdings A, and is a member of the Management Board at Bohrs Towers IVS.
Previously, he served as Chief Executive Officer at EpiTherapeutics ApS and Nykode Therapeutics ASA, Chairman at Dansk Biotek, and Director at MycoTeQ A.
He was also an Independent Director at Orphazyme A (2010-2022) and held principal positions at Arpida AG and Azanta A.
Dr. Bonde received his undergraduate degree from Copenhagen Business School and his graduate and doctorate degrees from the Technical University of Denmark.
Dr. Bonde is also the founder of Torsana A, CelTor Biosystems, Inc., Combio A, and Arpida A.
Postes actifs de Martin N. Bonde
| Sociétés | Poste | Début |
|---|---|---|
Visiopharm A/S
 Visiopharm A/S Packaged SoftwareTechnology Services Visiopharm A/S provides quantitative digital pathology solutions for biopharmaceutical companies, contract research organizations, academic medical centers, research institutes and hospitals. Its offers solutions such as BIOTOPIX, ONCOTOPIX, and STEREOTOPIX. The company was founded by Michael Grunkin and Johan Doré Hansen in 2001 and is headquartered in Horsholm, Denmark. | Director/Board Member | - |
| Bohrs Towers IVS | Corporate Officer/Principal | - |
| Biotopix ApS | Director/Board Member | - |
Inthera Bioscience AG
 Inthera Bioscience AG BiotechnologyHealth Technology Inthera Bioscience AG engages in the research in as well as development, production, and distribution of pharmaceutical, biological, and other products used in the fields of human and veterinary medicine. It also provides related consultancy services. The company was founded by Ulrich Kessler and Paramjit Singh Arora on September 20, 2013 and is headquartered in Zurich, Switzerland. | Chief Executive Officer | 01/06/2020 |
| Bohrs Tower ApS | Chief Executive Officer | - |
Bioinnovation Institute
 Bioinnovation Institute Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk A/S, Bioinnovation Institute is a non-profit foundation based in Copenhagen, Denmark. The Danish company offers a +1000 square meters of laboratory space to entrepreneurs and researchers in life science to bring interdisciplinary ideas to life and research to market. The program combines business acceleration, scientific development, and team development to help start-ups in the early phases. The CEO of the private company is Jens Nielsen. | Director/Board Member | - |
Bii Holdings A/S
 Bii Holdings A/S Miscellaneous Commercial ServicesCommercial Services Bii Holdings A/S is a non-profit organization that operates an incubator for startup businesses in science and technology. The Danish company was founded by Doron Cohen. | Director/Board Member | - |
Anciens postes connus de Martin N. Bonde
| Sociétés | Poste | Fin |
|---|---|---|
| ORPHAZYME A/S | Director/Board Member | 23/05/2022 |
MycoTeQ A/S
 MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | Director/Board Member | 02/04/2012 |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Formation de Martin N. Bonde
| Copenhagen Business School | Undergraduate Degree |
| Technical University of Denmark | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NYKODE THERAPEUTICS | Health Technology |
| ORPHAZYME A/S | Health Technology |
| Entreprise privées | 18 |
|---|---|
| Torsana A/S | Finance |
Arpida AG
 Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Health Technology |
Azanta Danmark A/S
 Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark. | Health Technology |
Visiopharm A/S
Visiopharm A/S Packaged SoftwareTechnology Services Visiopharm A/S provides quantitative digital pathology solutions for biopharmaceutical companies, contract research organizations, academic medical centers, research institutes and hospitals. Its offers solutions such as BIOTOPIX, ONCOTOPIX, and STEREOTOPIX. The company was founded by Michael Grunkin and Johan Doré Hansen in 2001 and is headquartered in Horsholm, Denmark. | Technology Services |
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | Health Technology |
| CelTor Biosystems, Inc. | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Health Technology |
| Combio A/S | |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Commercial Services |
| Arpida A/S | |
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Health Technology |
Aros Pharma ApS
 Aros Pharma ApS Pharmaceuticals: MajorHealth Technology Aros Pharma ApS is a holding company that develops medicine targeting unmet needs within pain relief, infectious disease, inflammation, respiratory diseases, and immuno-suppressed patients. It is a biotech company that focuses on clinical development of a novel therapy for the treatment of gastrointestinal pain. The firm is developing a new pain relief therapy based on a small molecule (PPC-5650) that is a specific inhibitor of the ASIC 1a receptor (Acid Sensing Ion Channel subtype 1a). Its therapy is currently being tested in two phase I trials targeting pain in patients who suffer from Irritable Bowel Syndrome (IBS) or non-erosive Gastroesophageal Reflux Disease (NERD). The company was founded in 2009 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Biotopix ApS | |
Inthera Bioscience AG
Inthera Bioscience AG BiotechnologyHealth Technology Inthera Bioscience AG engages in the research in as well as development, production, and distribution of pharmaceutical, biological, and other products used in the fields of human and veterinary medicine. It also provides related consultancy services. The company was founded by Ulrich Kessler and Paramjit Singh Arora on September 20, 2013 and is headquartered in Zurich, Switzerland. | Health Technology |
| Bohrs Towers IVS | |
Bioinnovation Institute
Bioinnovation Institute Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk A/S, Bioinnovation Institute is a non-profit foundation based in Copenhagen, Denmark. The Danish company offers a +1000 square meters of laboratory space to entrepreneurs and researchers in life science to bring interdisciplinary ideas to life and research to market. The program combines business acceleration, scientific development, and team development to help start-ups in the early phases. The CEO of the private company is Jens Nielsen. | Commercial Services |
| Bohrs Tower ApS | |
Bii Holdings A/S
Bii Holdings A/S Miscellaneous Commercial ServicesCommercial Services Bii Holdings A/S is a non-profit organization that operates an incubator for startup businesses in science and technology. The Danish company was founded by Doron Cohen. | Commercial Services |
